NeoGenomics Inc (MEX:NEO)
MXN 176.4 (0%) Market Cap: 34.15 Bil Enterprise Value: 38.75 Bil PE Ratio: 0 PB Ratio: 2.34 GF Score: 71/100

Neogenomics Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 01:15AM GMT
Release Date Price: MXN217.5
Zachary Conte
J.P. Morgan - Analyst

Thank you for joining us today. My name is Zach Conte. I'm with JPMorgan's Healthcare Investment Banking team. It is my pleasure to introduce NeoGenomics.

They'll be presenting. We're going to have a short presentation followed by a short Q&A. And I'll hand it over to CEO, Tony Zook.

Tony Zook
Neogenomics Inc - Chief Executive Officer, Director

Ready to begin? Well, welcome, everyone, and thank you very much for joining us here today to hear a little bit more about what's happening at NeoGenomics. With me today is Jeff Sherman, our CFO; and Warren Stone, our Chief Operating Officer.

And what I'd like to share at the beginning, at Neo, I think we have a mission that drives our people to come to work each and every day with a degree of passion that I haven't seen across many organizations. We're a team of over 2,500 strong. We show up every day with this personal connection to cancer, determined to make it better for those who are currently in the fight because the truth is essentially, everybody in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot